HLF — Herbalife Nutrition Ltd.

Summary of Herbalife Ltd. Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Q4 Net Sales: $1.3 billion, up 6.3% year-over-year, marking the second consecutive quarter of growth and exceeding guidance (1.5% to 5.5%).
• Full Year Net Sales: Just over $5 billion, a nearly 1% increase compared to 2024; adjusted for FX, net sales rose 2.5%.
• Q4 Adjusted EBITDA: $156 million, exceeding guidance of $144 million to $154 million, with a margin of 12.2%.
• Full Year Adjusted EBITDA: $658 million, with a margin of 13.1%, reflecting expansion for the second consecutive year.
• Operating Cash Flow: $333 million for the year, up 17% year-over-year.
• Debt Repayment: $283 million in 2025, reducing total leverage ratio from 3.9x to 2.8x.
• Q4 Net Income: $85 million, including $54 million in noncash deferred tax benefits.

2. Strategic Updates and Business Highlights

• Distributor Network Growth: North America saw a 19% increase in new distributors; Latin America achieved its seventh consecutive quarter of growth.
• Product Innovation: Successful launches included MultiBurn, HL/Skin, and Life I/O Baseline, enhancing the product portfolio.
• Digital Transformation: The Pro2col operating system is being rolled out to enhance distributor engagement and customer support, with a focus on personalized nutrition.
• Partnership with Cristiano Ronaldo: Ronaldo acquired a 10% stake in Herbalife's Pro2col Software, investing $7.5 million to enhance visibility and engagement.

3. Forward Guidance and Outlook

• Q1 2026 Guidance: Expected net sales growth of 3% to 7% year-over-year, with adjusted EBITDA projected between $155 million and $175 million.
• Full Year 2026 Guidance: Anticipated net sales growth of 1% to 6% year-over-year; adjusted EBITDA expected between $670 million and $710 million.
• Tax Rate: Expected adjusted effective tax rate for 2026 to be around 30%.

4. Bad News, Challenges, or Points of Concern

• China Market Decline: Anticipated continued challenges in China, with expected declines in net sales and volume.
• GST Impact in India: The reduction in GST has created a $16 million incremental cost affecting margins, which could hinder profitability despite driving volume growth.
• New Distributor Growth: While new distributors were down 5% year-over-year, the two-year stack shows a 16% increase, indicating mixed trends in recruitment.

5. Notable Q&A Insights

• Regional Sales Expectations: Growth is expected across most regions except China, where recovery is projected for 2027.
• Pro2col Sales Contribution: Minimal revenue from Pro2col is built into 2026 guidance as it remains in beta testing, with potential for upside.
• Distributor Events: Increased spending on distributor events is anticipated, reflecting a commitment to support the distributor network.
• Distributor and Member Dynamics: The relationship between distributor growth and preferred member growth is complex, with adjustments made to focus on preferred customers in 2025.

Overall, Herbalife demonstrated strong financial performance in Q4 2025, with strategic initiatives aimed at innovation and digital transformation. However, challenges in specific markets and the impact of regulatory changes present ongoing risks. The company remains optimistic about growth prospects for 2026.